These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1670664)

  • 1. Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis.
    Yoshizawa H; Nojiri N; Takahashi K
    Lancet; 1991 Jan; 337(8732):47-8. PubMed ID: 1670664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of post-transfusion non-A, non-B hepatitis].
    Habibi B; Smilovici W
    Rev Fr Transfus Immunohematol; 1988 Oct; 31(3):537-86. PubMed ID: 3144032
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening of blood donations for hepatitis C virus antibody.
    Kimber RJ
    Med J Aust; 1990 Jun; 152(11):613. PubMed ID: 2112223
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease.
    Sansonno D; Dammacco F
    Lancet; 1989 Sep; 2(8666):798-9. PubMed ID: 2571030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnosis and prevention of non-A, non-B viral hepatitis].
    Suzuki S
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):300-3. PubMed ID: 2110234
    [No Abstract]   [Full Text] [Related]  

  • 6. Infectivity of blood seropositive for hepatitis C virus antibodies.
    van der Poel CL; Reesink HW; Schaasberg W; Leentvaar-Kuypers A; Bakker E; Exel-Oehlers PJ; Lelie PN
    Lancet; 1990 Mar; 335(8689):558-60. PubMed ID: 1968574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transfusion non-A, non-B hepatitis: towards risk zero].
    de Andrade Júnior DR; de Andrade DR
    Arq Gastroenterol; 1992; 29(1):1-4. PubMed ID: 1284884
    [No Abstract]   [Full Text] [Related]  

  • 8. [Public Health Council advisory: prevention of post-transfusion non-A non-B hepatitis; is application of a surrogate test a missed station?].
    Brandt KH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2212-4. PubMed ID: 2509949
    [No Abstract]   [Full Text] [Related]  

  • 9. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of post-transfusion hepatitis non-A, non-B. Report established by the National Agency for the Development of Medical Evaluation on demand of the General Health Direction].
    Gayno S
    Gastroenterol Clin Biol; 1991; 15(8-9):667-8. PubMed ID: 1752387
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in non-A, non-B hepatitis research and the clinical significance of antibody to HCV].
    Furuta S; Kiyosawa K; Tanaka E; Sodeyama T; Shimizu S
    Nihon Rinsho; 1990 Jan; 48(1):39-46. PubMed ID: 2154636
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C virus infection and liver transplantation.
    Grendele M; Gridelli B; Colledan M; Rossi G; Rainero Fassati L; Ferla G; Lunghi G; Galmarini D
    Lancet; 1989 Nov; 2(8673):1221-2. PubMed ID: 2572934
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
    Hugo T; Wüst T; Beeser HP
    Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
    van der Poel CL; Reesink HW; Lelie PN; Leentvaar-Kuypers A; Choo QL; Kuo G; Houghton M
    Lancet; 1989 Aug; 2(8658):297-8. PubMed ID: 2569103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
    Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
    Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.